المؤلفون: Roelofzen JH; Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. J.Roelofzen@derma.umcn.nl, Aben KK, Oldenhof UT, Coenraads PJ, Alkemade HA, van de Kerkhof PC, van der Valk PG, Kiemeney LA

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2010 Apr; Vol. 130 (4), pp. 953-61. Date of Electronic Publication: 2009 Dec 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Coal Tar/*administration & dosage , Eczema/*drug therapy , Eczema/*epidemiology , Neoplasms/*epidemiology , Psoriasis/*drug therapy , Psoriasis/*epidemiology, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Coal Tar/adverse effects ; Female ; Humans ; Infant ; Infant, Newborn ; Keratolytic Agents/administration & dosage ; Keratolytic Agents/adverse effects ; Male ; Medical Records ; Middle Aged ; Proportional Hazards Models ; Risk Factors ; Surveys and Questionnaires ; Young Adult